Trial site
The Liver Institute at Methodist Dallas Medical Center
- 8running trials
- 10closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Primary biliary cholangitis7 trials
- Fatty liver disease (MASLD/MASH)6 trials
- Liver cirrhosis4 trials
- Liver and biliary tract cancer1 trial
- Phase
- Phase 28 trials
- Phase 37 trials
- Phase 12 trials
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting5 trials
- Recruiting3 trials
- Terminated3 trials
- Lead sponsor
- Gilead Sciences4 trials
- Madrigal Pharmaceuticals, Inc.3 trials
- Intercept Pharmaceuticals2 trials
- Mirum Pharmaceuticals, Inc.2 trials
- Aldeyra Therapeutics, Inc.1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Recruiting
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)1 recruiting
- Primary biliary cholangitis1 recruiting
Closed trials
Completed
Terminated
Completed
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Terminated
Terminated
FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study
Completed
Completed
Completed
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Site data: ClinicalTrials.govUpdated 18 Nov 2026